Author: admlappa

Welcome to the inaugural issue of the Case Law Monitor, the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...

In August 2019, the RAND Corporation (RAND) published an extensive, 265 page report on fentanyl entitled, The Future of Fentanyl and Other Synthetic Opioids (the Report). Considering the importance of the Report, the Legislative Analysis and Public Policy Association (LAPPA) designed this Fact Sheet to assist policymakers’ understanding of the Report by distilling key aspects into readily digestible paragraphs....

Currently, 35 states and the District of Columbia have enacted involuntary commitment laws for those suffering from alcoholism and/or substance use disorders (SUDs). In order to protect an individual’s civil rights, each state ensures that the committed person receives due process by providing the person the right to an attorney during the commitment process....

Started in 2003, Project ECHO (Extension for Community Healthcare Outcomes) combines primary and specialty care, linking “expert specialty teams” from an academic hub with primary care physicians (PCPs) in local, often rural, communities. This distance education model enables specialists to train and mentor PCPs to care for patients with complex health conditions....

Every year since 2013 the Rocky Mountain High Intensity Drug Trafficking Area (RMHIDTA) has published an annual report that tracks the overall impact of the legalization of recreational marijuana in the state of Colorado.  The stated purpose of these reports is to provide data that informs policy makers as they make decisions about marijuana legalization....

The co-authors of this recently released study used opioid mortality data obtained from the U.S. Centers for Disease Control and Prevention to compare opioid death rate trends in each marijuana-legalizing state and the District of Columbia prior to and after medicinal and recreational legalization implementation with associated trends in non-legalizing states. 78% of legalizing jurisdictions showed a statistically significant acceleration of opioid death rates after legalization implementation at greater rates than the pre-legalization rate or the concurrent rate in non-legalizing states....